The role of microbial amino acid metabolism in host metabolism.

Neis EP, Dejong CH, Rensen SS. · 2015

Read The role of microbial amino acid metabolism in host metabolism. by Neis EP, Dejong CH, Rensen SS. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4425181.txt.

Introduction

Evelien Neis, Cornelis Dejong, and Sander Rensen reviewed in Nutrients in 2015 how gut microbes handle amino acids, the building blocks of protein, and how that handling affects the host. Changes in gut microbes are increasingly tied to obesity, insulin resistance, and type 2 diabetes, and the products microbes release are part of that link.

Bacteria both take amino acids from food and body proteins and supply amino acids back to the host. Some microbe-made amino acids can also serve as raw material for short-chain fatty acids. Blood levels of certain amino acids, notably the branched-chain and aromatic kinds, run high in insulin resistance. The review weighs evidence that gut microbes help set those levels and may thus shape metabolic disease.

Catalog record

CREATORNeis EP, Dejong CH, Rensen SS.
YEAR2015
COLLECTIONPAPERS
FORMATTXT
FILE SIZE56 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4425181

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The Role of Microbial Amino Acid Metabolism in Host Metabolism By Evelien P J G Neis, Cornelis H C Dejong, Sander S Rensen Published in: Nutrients DOI: 10.3390/nu7042930 ABSTRACT Abstract Disruptions in gut microbiota composition and function are increasingly implicated in the pathogenesis of obesity, insulin resistance, and type 2 diabetes mellitus. The functional output of the gut microbiota, including short-chain fatty acids and amino acids, are thought to be important modulators underlying the development of these disorders. Gut bacteria can alter the bioavailability of amino acids by utilization of several amino acids originating from both alimentary and endogenous proteins. In turn, gut bacteria also provide amino acids to the host. This could have significant implications in the context of insulin resistance and type 2 diabetes mellitus, conditions associated with elevated systemic concentrations of certain amino acids, in particular the aromatic and branched-chain amino acids. Moreover, several amino acids released by gut bacteria can serve as precursors for the synthesis of short-chain fatty acids, which also play a role in the development of obesity. In this review, we aim to compile the available evidence on the contribution of microbial amino acids to host amino acid homeostasis, and to assess the role of the gut microbiota as a determinant of amino acid and short-chain fatty acid perturbations in human obesity and type 2 diabetes mellitus. Keywords: amino acids, short-chain fatty acids, gut microbiota, obesity, type 2 diabetes mellitus 1. INTRODUCTION Gut microbiota and its metabolites have a pivotal role in the maintenance of physiologic and metabolic homeostasis of the host [1]. The host and its indigenous microbiota exhibit numerous mutually beneficial and cooperative interactions. In particular, the metabolic activity of human gut microbes has been suggested to represent a virtual organ within an organ [2,3]. In recent years, this hidden metabolic organ [4]. has received renewed research interest for potential associations with human health. This idea already dates back to the early 1900s, when Metchnikoff first postulated the role of the gut in host physiology and pathology [5]. He proposed that gut bacteria are essential modulators influencing homeostasis and that deregulation of gut homeostasis by certain bacteria leads to a diseased state owing to poisoning of the body from bacterial byproducts. Indeed, the importance of disruption of the gut microbiota, or so-called dysbiosis, is now recognized in various conditions such as obesity [6,7,8,9,10], type 2 diabetes mellitus (T2DM) [11,12], chronic inflammatory diseases like inflammatory bowel disease [13], and colorectal cancer [14,15]. Moreover, clinical studies indicate that the administration of beneficial microbes via direct supplementation [16]. and/or fecal microbial transplantation [11]. can significantly modulate host hepatic and systemic lipid metabolism [9], energy balance [17], and glycemic control [18], which may reduce diet-induced obesity, insulin resistance, and T2DM. Although the underlying mechanisms require further investigation, there is an increasing body of evidence that the functional output of the gut microbiota, in particular bacterial metabolites like short chain fatty acids (SCFA) and amino acids, are important modulators of host physiology [19]. For example, the SCFA receptor GPR43 has been reported to link the metabolic activity of the gut microbiota with host energy homeostasis [20,21]. GPR43-deficient mice are obese on a normal diet, whereas mice overexpressing GPR43 remain lean even when fed a high-fat diet. Raised in the absence of microorganisms, both types of mice show a normal phenotype; SCFA-mediated activation of GPR43 appears to regulate fat accumulation in adipocytes and energy expenditure in other tissues, including liver and muscle, in order to maintain energy homeostasis [21]. Furthermore, studies in germ free and conventionalized mice reveal that gut bacteria alter the distribution of free amino acids in the gastrointestinal (GI) tract [22]. This may suggest that the gut microbiota affects the bioavailability of amino acids to the host. Interestingly, amino acids can also serve as precursors for the synthesis of SCFA by bacteria [23], suggesting an interplay between microbial activity and host amino acid and SCFA homeostasis. Importantly, emerging evidence links obesity, insulin resistance, and T2DM to elevated systemic concentrations of a small cluster of amino acids, the branched-chain amino acids (BCAA), in human adults [24]. These amino acid alterations are likely to contribute to the development of metabolic disease. For example, infusion of a cocktail of 18 amino acids including the BCAA leucine, isoleucine and valine has been shown to lead to decreased insulin sensitivity in man [25]. In view of the above, it is of interest to discuss microbial amino acid metabolism in the human GI tract in relation to its potential role in the development of obesity and related metabolic disorders. Hence, the objectives of this review are to compile the available evidence on the contribution of microbial amino acids to host amino acid homeostasis, and to assess the potential role of the gut microbiota as a determinant of amino acid and SCFA perturbations in human T2DM and obesity. 2. MICROBIAL AMINO ACID METABOLISM 2.1. Amino Acid Fermenting Microbes in the GI Tract The GI tract is the habitat of a highly diverse and dynamic microbial community, whose metagenome outnumbers the human genome over one hundred times [2]. This complex community is predominantly composed of bacterial species. The activities of these bacteria have potential effects on host nutrition and health through the metabolism of dietary components and through interaction with the intestinal epithelium [26]. As part of the major nutrients in the diet, amino acids should be particularly taken into account since they not only support the growth and survival of bacteria in the GI tract [27], but also regulate energy and protein homeostasis in organisms [28,29]. An early study already contributed to the hypothesis that gut bacteria may play an important role in host amino acid homeostasis and health by showing that germ free mice had an altered distribution of free amino acids along the GI tract as compared to conventionalized mice [30]. Along the GI tract, alimentary and endogenous proteins are hydrolyzed into peptides and amino acids by host- and bacteria-derived proteases and peptidases [22,31]. The released peptides and amino acids can be further utilized by both gut bacteria and the host. The most abundant amino acid fermenting bacteria in the human small intestine are bacteria belonging to the Clostridium clusters, the Bacillus-Lactobacillus-Streptococcus groups, and Proteobacteria [32]. In the large intestine of healthy humans, bacteria belonging to the Clostridia and Peptostreptococci appear to be the most prevalent species involved in amino acid fermentation [23,32,33]. These bacteria are therefore likely to be important for protein digestion and subsequent amino acid absorption in the GI tract [23]. Interestingly, intrabacterial amino acid composition varies among bacterial strains. Gut bacteria generally contain a higher proportion of BCAA relative to other amino acids [32]. Whether this may indicate increased BCAA synthesis and/or uptake, or decreased BCAA breakdown, and if this influences host BCAA availability remains to be determined. 2.2. Microbial Amino Acid Catabolism and Utilization When comparing amino acid absorption to the capacity of enterocytes for amino acid metabolism, it appears that the gut microbiota is likely to utilize certain amino acids in the small intestinal lumen. Upon uptake by bacteria, amino acids can be either directly incorporated into bacterial cells as protein building blocks, or become catabolized. In an early study in milk-fed piglets

Read the complete text